Cargando…

Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma

PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The aim of this study was to evaluate prognostic factors and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ik Jae, Kim, Jun Won, Han, Kwang Hyub, Kim, Ja Kyung, Kim, Kyung Sik, Choi, Jin Sub, Park, Young Nyun, Seong, Jinsil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205687/ https://www.ncbi.nlm.nih.gov/pubmed/25323884 http://dx.doi.org/10.3349/ymj.2014.55.6.1489

Ejemplares similares

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
por: Cha, Hyejung, et al.
Publicado: (2013)

Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Yoon, Hong In, et al.
Publicado: (2016)

Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
por: Choi, Yunseon, et al.
Publicado: (2014)

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
por: Han, Sojung, et al.
Publicado: (2020)

The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
por: Choi, Sae Byeol, et al.
Publicado: (2009)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)

Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
por: Han, Dai Hoon, et al.
Publicado: (2016)

Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
por: Kim, Beom Kyung, et al.
Publicado: (2019)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Preoperative Radiologic and Postoperative Pathologic Risk Factors for Early Intra-Hepatic Recurrence in Hepatocellular Carcinoma Patients Who Underwent Curative Resection
por: Kim, Honsoul, et al.
Publicado: (2009)

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
por: Cho, In Rae, et al.
Publicado: (2017)

The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma
por: Yoon, Hong In, et al.
Publicado: (2016)

Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years
por: Han, Dai Hoon, et al.
Publicado: (2014)

Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study
por: Kim, Ja Kyung, et al.
Publicado: (2017)

Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan(®)) before curative resection of hepatocellular carcinoma: a pilot study
por: Kim, Seung Up, et al.
Publicado: (2008)

Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
por: Suh, Yang-Gun, et al.
Publicado: (2014)

Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer
por: Kim, Hwan-Ik, et al.
Publicado: (2016)

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
por: Kim, Hye Soo, et al.
Publicado: (2020)

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
por: Noh, Minho, et al.
Publicado: (2021)

Primary cardiac angiosarcoma: a prolonged response to surgical resection followed by concurrent chemoradiotherapy with docetaxel
por: Jang, Youngwoo, et al.
Publicado: (2016)

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
por: Byun, Hwa Kyung, et al.
Publicado: (2023)

Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
por: Cho, Yeona, et al.
Publicado: (2020)

Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
por: Kim, Hyera, et al.
Publicado: (2020)

Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
por: Im, Jung Ho, et al.
Publicado: (2016)

Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
por: Kim, Hyera, et al.
Publicado: (2020)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015)

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
por: Kim, Seung Up, et al.
Publicado: (2012)

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
por: Jeon, Mi Young, et al.
Publicado: (2019)

Gastrointestinal Hemorrhage after Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma
por: Hong, Young Ju, et al.
Publicado: (2011)

Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer
por: Jeong, Jae-Uk, et al.
Publicado: (2016)

Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
por: Jung, Kyu Sik, et al.
Publicado: (2014)

Hepatic Splenosis Preoperatively Diagnosed as Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B: A Case Report
por: Choi, Gi-Hong, et al.
Publicado: (2008)

The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative Resection
por: Lee, Jae Gil, et al.
Publicado: (2006)

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study
por: Choi, Younak, et al.
Publicado: (2016)

The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2012)

High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
por: Kim, Taehyung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4r1b5jdrb59771p3mq68j3m6sp